Royal Bank Of Canada Alx Oncology Holdings Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 8,370 shares of ALXO stock, worth $10,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,370

Previous 3,106 169.48%

Holding current value

$10,797

Previous $18,000 16.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $9,527 - $42,796	5,264 Added 169.48%	8,370 $15,000
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $14,635 - $44,005	2,506 Added 417.67%	3,106 $18,000
Q1 2024 Nov 05, 2024	SELL	$10.95 - $16.79 $27,440 - $42,075	-2,506 Reduced 80.68%	600 $6,000
Q1 2024 May 15, 2024	SELL	$10.95 - $16.79 $85,782 - $131,532	-7,834 Reduced 92.89%	600 $6,000
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $22,866 - $73,116	4,754 Added 129.18%	8,434 $125,000
Q3 2023 Nov 14, 2023	SELL	$4.19 - $7.35 $1,344 - $2,359	-321 Reduced 8.02%	3,680 $17,000
Q2 2023 Aug 14, 2023	BUY	$4.37 - $9.56 $12,131 - $26,538	2,776 Added 226.61%	4,001 $30,000
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $6,947 - $17,998	-1,537 Reduced 55.65%	1,225 $5,000
Q4 2022 Feb 14, 2023	BUY	$9.51 - $12.95 $23,784 - $32,387	2,501 Added 958.24%	2,762 $31,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $1,160 - $2,134	141 Added 117.5%	261 $2,000
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $5,707 - $18,856	-969 Reduced 88.98%	120 $1,000
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $27,900 - $45,090	-2,044 Reduced 65.24%	1,089 $18,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $65,007 - $225,060	3,025 Added 2800.93%	3,133 $67,000
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $4,463 - $6,877	85 Added 369.57%	108 $8,000
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $1,200 - $1,730	23 New	23 $1,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $52.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Alx Oncology Holdings Inc Transaction History